Dec 20, 2013, 06.03 PM IST
Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.
Tags Arvind Bothra, Religare Cap Mkts , Sun Pharma, Dr Reddys Labs, Glenmark, Divis Labs, Lupin, Ipca Labs
Like this story, share it with millions of investors on M3
Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra
Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.
Like this story, share it with millions of investors on M3
Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra
Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.
He further added, "Lupin satisfies all these three criteria and what we are looking at going forward is high number of launches in the US which are margin-accretive. So starting with Trilipix, Trizivir and Cymbalta in this quarter you would have Yaz, Renagel or possibly Niaspan with extended low competition period to sustain in the second half. We are also looking at a domestic market growth recovery for Lupin."
"I like Sun Pharma for deep quality of its pipeline and sustained earnings surprises and Dr Reddy's is third on the pecking order. Among the midcaps, I like Ipca Labs and Divis Laboratories followed by Glenmark Pharma . All these three stories are relatively low on valuations and fairly stable businesses," Bothra said.
Anda sedang membaca artikel tentang
Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra
Dengan url
http://harmonisem.blogspot.com/2013/12/lupin-sun-pharma-dr-reddys-top-picks.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra
namun jangan lupa untuk meletakkan link
Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra
sebagai sumbernya
0 komentar:
Posting Komentar